Drugs / Bifidobacteria lactis
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00835874 | Jun 2007 → Jul 2009 | infectious disease with sepsis, necrotizing enterocolitis | Tel-Aviv Sourasky Medical Center | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bifidobacteria lactis | “Mothers were assigned to supplementation with Lactobacillus acidophilus and Bifidobacteria lactis 2 × 10(E) [DOSAGE ERROR CORRECTED] CFU/d or to placebo” PMID 23934538 ↗ Aug 2013 |
| Modality | Other / unclassified | “administered probiotic bacteria to mothers of preterm infants” PMID 23934538 ↗ Aug 2013 |
| Route | Oral | “maternal oral probiotic supplementation” PMID 23934538 ↗ Aug 2013 |